Nextgen Biomed Ltd (NXGN.TA)
ILA 66.5
(0.15%)
ILA 66.5
(0.15%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 261 Thousand ILS | -98.25% |
| 2022 | 14.88 Million ILS | -36.99% |
| 2021 | 23.62 Million ILS | 183.98% |
| 2020 | 8.32 Million ILS | 330.42% |
| 2019 | 1.93 Million ILS | -38.01% |
| 2018 | 3.11 Million ILS | -28.34% |
| 2017 | 4.35 Million ILS | -27.35% |
| 2016 | 5.98 Million ILS | 142.47% |
| 2015 | 2.47 Million ILS | -25.69% |
| 2014 | 3.32 Million ILS | 141.57% |
| 2013 | 1.37 Million ILS | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 822 Thousand ILS | 214.94% |
| 2024 Q2 | 822 Thousand ILS | 0.0% |
| 2023 Q3 | 261 Thousand ILS | -97.96% |
| 2023 Q1 | 12.81 Million ILS | -13.92% |
| 2023 FY | 261 Thousand ILS | -98.25% |
| 2023 Q2 | 12.81 Million ILS | 0.0% |
| 2023 Q4 | 261 Thousand ILS | 0.0% |
| 2022 Q2 | 22.08 Million ILS | 0.0% |
| 2022 FY | 14.88 Million ILS | -36.99% |
| 2022 Q4 | 14.88 Million ILS | 0.0% |
| 2022 Q1 | 22.08 Million ILS | -6.51% |
| 2022 Q3 | 14.88 Million ILS | -32.6% |
| 2021 Q3 | 23.62 Million ILS | 21.89% |
| 2021 Q2 | 19.38 Million ILS | 0.0% |
| 2021 Q4 | 23.62 Million ILS | 0.0% |
| 2021 Q1 | 19.38 Million ILS | 132.98% |
| 2021 FY | 23.62 Million ILS | 183.98% |
| 2020 FY | 8.32 Million ILS | 330.42% |
| 2020 Q2 | 1.21 Million ILS | 0.0% |
| 2020 Q1 | 1.21 Million ILS | -37.2% |
| 2020 Q4 | 8.32 Million ILS | 0.0% |
| 2020 Q3 | 8.32 Million ILS | 585.34% |
| 2019 Q1 | 2.66 Million ILS | -14.59% |
| 2019 Q2 | 2.66 Million ILS | 0.0% |
| 2019 Q3 | 1.93 Million ILS | -27.41% |
| 2019 Q4 | 1.93 Million ILS | 0.0% |
| 2019 FY | 1.93 Million ILS | -38.01% |
| 2018 Q2 | 3.84 Million ILS | 0.0% |
| 2018 FY | 3.11 Million ILS | -28.34% |
| 2018 Q3 | 3.11 Million ILS | -18.89% |
| 2018 Q4 | 3.11 Million ILS | 0.0% |
| 2018 Q1 | 3.84 Million ILS | -11.65% |
| 2017 Q4 | 4.35 Million ILS | 0.0% |
| 2017 FY | 4.35 Million ILS | -27.35% |
| 2017 Q1 | 5.23 Million ILS | -12.52% |
| 2017 Q3 | 4.35 Million ILS | -16.95% |
| 2017 Q2 | 5.23 Million ILS | 0.0% |
| 2016 Q1 | 2.18 Million ILS | -11.46% |
| 2016 Q2 | 1.73 Million ILS | -20.62% |
| 2016 FY | 5.98 Million ILS | 142.47% |
| 2016 Q3 | 6.44 Million ILS | 271.37% |
| 2016 Q4 | 5.98 Million ILS | -7.1% |
| 2015 Q3 | 3.2 Million ILS | 653.29% |
| 2015 Q4 | 2.47 Million ILS | -23.03% |
| 2015 Q2 | 426 Thousand ILS | -68.4% |
| 2015 Q1 | 1.34 Million ILS | -59.45% |
| 2015 FY | 2.47 Million ILS | -25.69% |
| 2014 Q4 | 3.32 Million ILS | 154.71% |
| 2014 Q2 | 826 Thousand ILS | -34.08% |
| 2014 Q3 | 1.3 Million ILS | 57.99% |
| 2014 FY | 3.32 Million ILS | 141.57% |
| 2014 Q1 | 1.25 Million ILS | -8.94% |
| 2013 Q3 | 1.67 Million ILS | 7173.91% |
| 2013 Q2 | 23 Thousand ILS | 0.0% |
| 2013 Q1 | - ILS | 0.0% |
| 2013 Q4 | 1.37 Million ILS | -17.75% |
| 2013 FY | 1.37 Million ILS | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|